Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Medipharm Labs Corp
T.LABS
Alternate Symbol(s):
MEDIF
Healthcare
Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,...
packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:LABS)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
...
Next
(22)
•••
Lvlchange
X
View Profile
View Bullboard History
Comment by
Lvlchange
on Apr 17, 2024 11:40pm
RE:Interesting read
So stupid.
(571)
•••
mdjbrown
X
View Profile
View Bullboard History
Post by
mdjbrown
on Apr 17, 2024 11:33pm
Interesting read
https://www.marijuanamoment.net/cbd-is-a-powerful-and-promising-treatment-for-crack-use-disorder-with-fewer-side-effects-than-conventional-therapies-study-finds/
(80)
•••
Starkicker
X
View Profile
View Bullboard History
Comment by
Starkicker
on Apr 17, 2024 3:35pm
RE:No love lost for the Canadian gov from the big players
Unfortunate it wasn't in the budget, but because it wasn't doesn't mean the recommendations aren't being considered and excise tax breaks could be addressed later. It was a tight
...more
(603)
•••
subaru1i
X
View Profile
View Bullboard History
Post by
subaru1i
on Apr 17, 2024 2:44pm
Generic epidiolex is CBD based
And is independent of any decision by the DEA, just another way of saying we could hear news at any moment with approval by the fda.
(603)
•••
subaru1i
X
View Profile
View Bullboard History
Comment by
subaru1i
on Apr 17, 2024 12:32pm
RE:No love lost for the Canadian gov from the big players
Trudeau and his liberal government has made a really big mess of everything not just cannabis, not just housing, not just immigration but to hear a hospital doctor say it's a dumpster fire with
...more
(571)
•••
mdjbrown
X
View Profile
View Bullboard History
Post by
mdjbrown
on Apr 17, 2024 12:26pm
No love lost for the Canadian gov from the big players
in the MJ sector.............. Why does the Canadian government have a House of Commons Standing Committee on Finance, if they are completely ignored? "The House of Commons Standing Committee
...more
(264)
•••
alleyesonme
X
View Profile
View Bullboard History
Comment by
alleyesonme
on Apr 17, 2024 10:00am
RE:RE:RE:RE:RE:RE:The success of LABS
The ANDA could be for the current form of epidiolex and its approved indications, whereas the 505b2 is CBDaka cannabidol , epidiolex, for a new indication, dosage as a tab, therefore not infringing on
...more
(603)
•••
subaru1i
X
View Profile
View Bullboard History
Comment by
subaru1i
on Apr 17, 2024 8:22am
RE:RE:RE:RE:RE:The success of LABS
The application of a generic form of epidiolex for opiate addiction is very interesting and recall that the CEO did state that some of the data for the ANDA was from another party and I am now
...more
(603)
•••
subaru1i
X
View Profile
View Bullboard History
Comment by
subaru1i
on Apr 17, 2024 8:17am
RE:RE:RE:RE:The success of LABS
The CEO made the statement that they will be launching generic epidiolex for the US market this year!
(603)
•••
subaru1i
X
View Profile
View Bullboard History
Comment by
subaru1i
on Apr 17, 2024 8:14am
RE:RE:RE:The success of LABS
I personally believe they could be using the SEDDS technology which is a totally different delivery format than non-generic version of epidiolex
(100)
•••
Solid1
X
View Profile
View Bullboard History
Comment by
Solid1
on Apr 17, 2024 3:40am
RE:RE:RE:RE:The success of LABS
And let's not forget Dr. Yasmin Hurd, a pioneer in addiction research who has been working with the FDA on the use of CBD since early 2023. Dr. Yasmin Hurd has also worked with Medipharm Labs (but
...more
(100)
•••
Solid1
X
View Profile
View Bullboard History
Comment by
Solid1
on Apr 17, 2024 2:25am
RE:RE:RE:The success of LABS
Teva tried to market a generic version of Epidiolex for the treatment of epilepsy, but was rejected by the courts.
(100)
•••
Solid1
X
View Profile
View Bullboard History
Comment by
Solid1
on Apr 17, 2024 2:23am
RE:RE:The success of LABS
If the generic drug is a completely new treatment method, nothing stands in the way of approval! The active ingredients of Epidiolex are not patentable. JAZZ's patents relate to the treatment of
...more
(615)
•••
okgonow
X
View Profile
View Bullboard History
Comment by
okgonow
on Apr 16, 2024 10:02pm
RE:The success of LABS
not if the courts in the US keep ruling like this: From Jan of this year Jazz Pharmaceuticals has rebuffed attempts by rival Teva Pharmaceuticals to legally disqualify its patent
...more
Prev
...
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >